Ustekinumab Inhibits T Follicular Helper Cell Differentiation in Patients With Crohn’s Disease

BACKGROUND & AIMS: The pathogenesis of chronic inflammatory bowel diseases (Crohn’s disease [CD] and ulcerative colitis) involves dysregulated TH1 and TH17 cell responses, which can be targeted therapeutically by the monoclonal antibody Ustekinumab directed against the joint p40 subunit of IL-12...

Descripción completa

Detalles Bibliográficos
Autores principales: Globig, Anna-Maria, Sommer, Nikola Patricia, Wild, Katharina, Schardey, Josefine, Zoldan, Katharina, Thomann, Anne Kerstin, Schulte, Lucas-Alexander, Schreiner, Rupert, Reindl, Wolfgang, Klaus, Jochen, Schempp, Christoph Mathis, Hofmann, Maike, Thimme, Robert, Boettler, Tobias, Hasselblatt, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593584/
https://www.ncbi.nlm.nih.gov/pubmed/32679193
http://dx.doi.org/10.1016/j.jcmgh.2020.07.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593584/
https://www.ncbi.nlm.nih.gov/pubmed/32679193
http://dx.doi.org/10.1016/j.jcmgh.2020.07.005

Ejemplares similares